Harald Paganetti

Harald Paganetti's AcademicInfluence.com Rankings

Harald Paganetti

Physics

#4377

World Rank

#6027

Historical Rank

physics Degrees

Download Badge

Physics

Harald Paganetti's Degrees

PhD Medical Physics Ludwig Maximilian University of Munich

Why Is Harald Paganetti Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Harald Paganetti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Relative biological effectiveness (RBE) values for proton beam therapy. (2002) (1170)
Range uncertainties in proton therapy and the role of Monte Carlo simulations (2012) (951)
Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer (2014) (633)
TOPAS: an innovative proton Monte Carlo platform for research and clinical applications. (2012) (606)
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction (2008) (403)
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. (2007) (355)
Clinical implementation of full Monte Carlo dose calculation in proton beam therapy (2008) (255)
Secondary Carcinogenesis in Patients Treated with Radiation: A Review of Data on Radiation-Induced Cancers in Human, Non-human Primate, Canine and Rodent Subjects (2007) (244)
Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. (2004) (232)
A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data (2015) (232)
Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. (2010) (230)
Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles. (2002) (217)
Range uncertainty in proton therapy due to variable biological effectiveness (2011) (209)
Nuclear physics in particle therapy: a review (2016) (204)
Physics Settings for Using the Geant4 Toolkit in Proton Therapy (2008) (191)
AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy. (2017) (182)
Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. (2013) (181)
Breathing interplay effects during proton beam scanning: simulation and statistical analysis (2009) (173)
Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code (2007) (168)
Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning. (2011) (168)
Metal Artifact Reduction in CT: Where Are We After Four Decades? (2016) (168)
Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy (2011) (154)
Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. (2019) (151)
GPU-based fast Monte Carlo dose calculation for proton therapy (2012) (146)
Elevated LET components in clinical proton beams (2011) (146)
PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants. (2007) (144)
Adaptation of GEANT4 to Monte Carlo dose calculations based on CT data. (2004) (139)
Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: a Monte Carlo simulation (2014) (137)
Proton Beams to Replace Photon Beams in Radical Dose Treatments (2003) (133)
Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer. (2016) (132)
Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment (2005) (130)
Interplay effects in proton scanning for lung: a 4D Monte Carlo study assessing the impact of tumor and beam delivery parameters (2013) (128)
Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential. (2013) (121)
Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans (2009) (115)
Monitoring proton radiation therapy with in-room PET imaging (2011) (107)
Proton therapy physics (2011) (106)
Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field (2012) (106)
Biological modeling of gold nanoparticle enhanced radiotherapy for proton therapy (2015) (106)
Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age. (2008) (105)
Tissue decomposition from dual energy CT data for MC based dose calculation in particle therapy. (2014) (103)
Site-specific range uncertainties caused by dose calculation algorithms for proton therapy (2014) (103)
National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. (2018) (101)
Metal artifacts in computed tomography for radiation therapy planning: dosimetric effects and impact of metal artifact reduction (2017) (97)
TOPAS-nBio: An Extension to the TOPAS Simulation Toolkit for Cellular and Sub-cellular Radiobiology (2018) (96)
Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury. (2016) (95)
Significance and Implementation of RBE Variations in Proton Beam Therapy (2003) (94)
Biological considerations when comparing proton therapy with photon therapy. (2013) (94)
Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapy. (2013) (94)
Effects of organ motion on IMRT treatments with segments of few monitor units. (2007) (93)
Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation. (2014) (93)
Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. (2011) (93)
Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms (2008) (93)
Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. (2008) (92)
Dose to water versus dose to medium in proton beam therapy (2009) (89)
Accuracy of proton beam range verification using post-treatment positron emission tomography/computed tomography as function of treatment site. (2011) (88)
Effects of Hounsfield number conversion on CT based proton Monte Carlo dose calculations. (2007) (87)
Monte Carlo simulations with time-dependent geometries to investigate effects of organ motion with high temporal resolution. (2004) (86)
Quantitative assessment of the physical potential of proton beam range verification with PET/CT (2008) (84)
Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver (2011) (80)
Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy. (2015) (78)
Robust Proton Treatment Planning: Physical and Biological Optimization. (2018) (77)
4D Monte Carlo simulation of proton beam scanning: modelling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry (2005) (76)
Calculation of relative biological effectiveness for proton beams using biological weighting functions. (1997) (75)
The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors (2014) (75)
Mechanistic Modelling of DNA Repair and Cellular Survival Following Radiation-Induced DNA Damage (2016) (74)
Clinical application of in-room positron emission tomography for in vivo treatment monitoring in proton radiation therapy. (2013) (73)
PET imaging for treatment verification of ion therapy: Implementation and experience at GSI Darmstadt and MGH Boston (2008) (73)
Optimising element choice for nanoparticle radiosensitisers. (2015) (73)
Lung cancer cell line screen links fanconi anemia/BRCA pathway defects to increased relative biological effectiveness of proton radiation. (2015) (72)
Assessment of out-of-field absorbed dose and equivalent dose in proton fields. (2009) (72)
The TOPAS tool for particle simulation, a Monte Carlo simulation tool for physics, biology and clinical research. (2020) (71)
Dosimetric impact of motion in free-breathing and gated lung radiotherapy: a 4D Monte Carlo study of intrafraction and interfraction effects. (2007) (71)
Asymptomatic Late-phase Radiographic Changes Among Chest-Wall Patients Are Associated With a Proton RBE Exceeding 1.1. (2018) (71)
Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. (2014) (70)
Motion mitigation for lung cancer patients treated with active scanning proton therapy. (2015) (70)
Proton radiography and proton computed tomography based on time-resolved dose measurements (2013) (70)
Biophysical modelling of proton radiation effects based on amorphous track models (2001) (69)
The reliability of proton-nuclear interaction cross-section data to predict proton-induced PET images in proton therapy (2011) (68)
Quantification of proton dose calculation accuracy in the lung. (2014) (68)
Four-dimensional Monte Carlo simulation of time-dependent geometries. (2004) (67)
Neutron dose in proton radiation therapy: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7). (2006) (66)
Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients (2010) (63)
In vivo proton beam range verification using spine MRI changes. (2010) (62)
Dosimetric feasibility of real-time MRI-guided proton therapy. (2014) (62)
Radiobiological significance of beamline dependent proton energy distributions in a spread-out Bragg peak. (2000) (62)
Extension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints (2015) (62)
Validation of the radiobiology toolkit TOPAS-nBio in simple DNA geometries. (2017) (61)
Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy. (2005) (61)
Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model (2017) (61)
The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions (2010) (60)
Monte Carlo calculations for absolute dosimetry to determine machine outputs for proton therapy fields (2006) (59)
Extension and validation of an analytical model for in vivo PET verification of proton therapy—a phantom and clinical study (2011) (59)
Relating proton treatments to photon treatments via the relative biological effectiveness-should we revise current clinical practice? (2015) (58)
Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator (2009) (57)
The prediction of output factors for spread-out proton Bragg peak fields in clinical practice (2005) (56)
Nuclear interactions of 160 MeV protons stopping in copper: a test of Monte Carlo nuclear models. (1999) (54)
Test of GEANT3 and GEANT4 nuclear models for 160 MeV protons stopping in CH2. (2003) (54)
Technology for Innovation in Radiation Oncology. (2015) (53)
Dependence of gold nanoparticle radiosensitization on cell geometry. (2017) (50)
Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy. (2016) (49)
Efficient voxel navigation for proton therapy dose calculation in TOPAS and Geant4 (2012) (49)
Monte Carlo method to study the proton fluence for treatment planning. (1998) (49)
Calculation of the spatial variation of relative biological effectiveness in a therapeutic proton field for eye treatment. (1998) (48)
Monte Carlo study of the potential reduction in out-of-field dose using a patient-specific aperture in pencil beam scanning proton therapy (2012) (47)
Monte Carlo simulation of chemistry following radiolysis with TOPAS-nBio (2018) (47)
Proton Relative Biological Effectiveness – Uncertainties and Opportunities (2018) (47)
Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy (2009) (46)
Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol (2016) (46)
Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes (2010) (45)
Roadmap: proton therapy physics and biology (2020) (44)
Validation of a GPU-based Monte Carlo code (gPMC) for proton radiation therapy: clinical cases study (2015) (44)
Characterizing a proton beam scanning system for Monte Carlo dose calculation in patients (2015) (44)
A general mechanistic model enables predictions of the biological effectiveness of different qualities of radiation (2017) (44)
The clinical impact of uncertainties in the mean excitation energy of human tissues during proton therapy (2013) (44)
Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy (2014) (44)
The influence of the beam modulation technique on dose and RBE in proton radiation therapy. (1996) (43)
Variable Proton Relative Biological Effectiveness: How Do We Move Forward? (2016) (42)
LET-weighted doses effectively reduce biological variability in proton radiotherapy planning (2018) (41)
Proton Beam Radiotherapy - The State of the Art 1 (2005) (40)
Characterization of proton pencil beam scanning and passive beam using a high spatial resolution solid‐state microdosimeter (2017) (40)
A New Standard DNA Damage (SDD) Data Format (2018) (39)
Assessment of the Risk for Developing a Second Malignancy From Scattered and Secondary Radiation In Radiation Therapy (2012) (39)
Comparison of MCNPX and Geant4 proton energy deposition predictions for clinical use (2012) (39)
A deconvolution approach for PET-based dose reconstruction in proton radiotherapy (2011) (39)
Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors. (2017) (38)
Online adaption approaches for intensity modulated proton therapy for head and neck patients based on cone beam CTs and Monte Carlo simulations (2018) (38)
End-of-range Radiobiological Effect on Rib Fractures in Patients Receiving Proton Therapy for Breast Cancer. (2020) (38)
MO‐A‐T‐6B‐01: Proton Beam Radiotherapy — The State of the Art (2005) (38)
Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons. (2015) (37)
The biologic relevance of daily dose variations in adaptive treatment planning. (2006) (36)
Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β (2017) (36)
Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy. (2016) (36)
Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk. (2017) (36)
Range verification of passively scattered proton beams based on prompt gamma time patterns (2014) (35)
Field size dependence of the output factor in passively scattered proton therapy: influence of range, modulation, air gap, and machine settings. (2009) (34)
Radiobiological Intercomparison of the 160 MeV and 230 MeV Proton Therapy Beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital (2015) (33)
Relative Biological Effectiveness Uncertainties and Implications for Beam Arrangements and Dose Constraints in Proton Therapy. (2018) (33)
Experimental assessment of proton dose calculation accuracy in inhomogeneous media. (2017) (32)
Assessing the radiation-induced second cancer risk in proton therapy for pediatric brain tumors: the impact of employing a patient-specific aperture in pencil beam scanning (2015) (32)
Geometrical structures for radiation biology research as implemented in the TOPAS-nBio toolkit (2018) (32)
Uncertainties in planned dose due to the limited voxel size of the planning CT when treating lung tumors with proton therapy (2011) (32)
The influence of patient positioning uncertainties in proton radiotherapy on proton range and dose distributions. (2014) (31)
Recent developments and comprehensive evaluations of a GPU-based Monte Carlo package for proton therapy (2016) (31)
Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses. (2014) (30)
A dual-stream deep convolutional network for reducing metal streak artifacts in CT images (2019) (30)
Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk. (2012) (30)
Modelling variable proton relative biological effectiveness for treatment planning. (2019) (29)
The general relation between tissue response to x-radiation (α/β-values) and the relative biological effectiveness (RBE) of protons: Prediction by the Katz track-structure model (2000) (29)
Extension of the NCAT phantom for the investigation of intra-fraction respiratory motion in IMRT using 4D Monte Carlo (2010) (28)
Attitudes of radiation oncologists toward palliative and supportive care in the United States: Report on national membership survey by the American Society for Radiation Oncology (ASTRO). (2017) (28)
Direct absorbed dose to water determination based on water calorimetry in scanning proton beam delivery. (2010) (28)
Evaluation of CBCT scatter correction using deep convolutional neural networks for head and neck adaptive proton therapy (2020) (28)
Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation (2014) (27)
Monte Carlo simulations will change the way we treat patients with proton beams today. (2014) (27)
Geometrical splitting technique to improve the computational efficiency in Monte Carlo calculations for proton therapy. (2012) (27)
Dosimetric accuracy of planning and delivering small proton therapy fields (2010) (27)
Brain necrosis in adult patients after proton therapy: Is there evidence for dependency on linear energy transfer (LET)? (2020) (27)
An algorithm to assess the need for clinical Monte Carlo dose calculation for small proton therapy fields based on quantification of tissue heterogeneity. (2013) (26)
Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton Radiation. (2016) (26)
Interpretation of proton relative biological effectiveness using lesion induction, lesion repair, and cellular dose distribution. (2005) (26)
A parameter sensitivity study for simulating DNA damage after proton irradiation using TOPAS-nBio (2020) (26)
Adaptive proton therapy (2021) (25)
Dose assessment for the fetus considering scattered and secondary radiation from photon and proton therapy when treating a brain tumor of the mother (2016) (24)
Uncertainties and correction methods when modeling passive scattering proton therapy treatment heads with Monte Carlo (2011) (24)
Principles and Practice of Proton Beam Therapy (2015) (23)
Patient-specific tumor growth trajectories determine persistent and resistant cancer cell populations during treatment with targeted therapies. (2019) (23)
Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. (2019) (23)
Mapping (15)O production rate for proton therapy verification. (2015) (23)
Validation of nuclear models in Geant4 using the dose distribution of a 177 MeV proton pencil beam (2015) (23)
Automated Monte Carlo Simulation of Proton Therapy Treatment Plans (2016) (23)
The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques. (2020) (22)
Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial. (2019) (22)
A Tumor-Immune Interaction Model for Hepatocellular Carcinoma based on measured Lymphocyte Counts in Patients undergoing Radiotherapy. (2019) (21)
Synergizing medical imaging and radiotherapy with deep learning (2020) (21)
A modular method to handle multiple time-dependent quantities in Monte Carlo simulations (2012) (21)
The FLUKA code for application of Monte Carlo methods to promote high precision ion beam therapy (2010) (21)
Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients. (2017) (20)
Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy (2008) (20)
The microdosimetric extension in TOPAS: development and comparison with published data (2019) (20)
Comparison of weekly and daily online adaptation for head and neck intensity-modulated proton therapy (2021) (19)
Report of a National Cancer Institute special panel: Characterization of the physical parameters of particle beams for biological research (2018) (19)
Anatomic changes in head and neck intensity-modulated proton therapy: comparison between robust optimization and online adaptation. (2021) (18)
An integral test of FLUKA nuclear models with 160 MeV proton beams in multi-layer Faraday cups (2011) (18)
Relative biological effectiveness (RBE) and out-of-field cell survival responses to passive scattering and pencil beam scanning proton beam deliveries (2012) (18)
Cellular Response to Proton Irradiation: A Simulation Study with TOPAS-nBio (2020) (18)
Predicting Patient-specific Dosimetric Benefits of Proton Therapy for Skull-base Tumors Using a Geometric Knowledge-based Method. (2017) (18)
Feasibility of proton-activated implantable markers for proton range verification using PET (2013) (17)
Methodologies in the modeling of combined chemo-radiation treatments (2016) (17)
Monitoring proton therapy with PET. (2015) (17)
Four-dimensional Monte Carlo simulations demonstrating how the extent of intensity-modulation impacts motion effects in proton therapy lung treatments. (2013) (17)
Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy. (2010) (17)
Varying relative biological effectiveness in proton therapy: knowledge gaps versus clinical significance (2017) (17)
Proton radiation in the management of localized cancer (2010) (16)
Proton Beam Therapy (2016) (16)
Mitochondria as a target for radiosensitisation by gold nanoparticles (2017) (14)
Test of the nuclear interaction model in SHIELD-HIT and comparison to energy distributions from GEANT4 (2009) (14)
ICRP Publication 127: Radiological Protection in Ion Beam Radiotherapy (2014) (14)
Determination of elemental tissue composition following proton treatment using positron emission tomography (2013) (14)
Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams (2017) (13)
Better radiation weighting factors for neutrons generated from proton treatment are needed. (2010) (13)
Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy? (2018) (13)
Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions. (2013) (13)
4D blood flow model for dose calculation to circulating blood and lymphocytes (2020) (13)
Photon radiotherapy has reached its limit in terms of catching up dosimetrically with proton therapy. (2016) (13)
Impact of potentially variable RBE in liver proton therapy (2018) (11)
Consistency in quality correction factors for ionization chamber dosimetry in scanned proton beam therapy (2017) (11)
HEDOS—a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations (2021) (11)
Repair kinetic considerations in particle beam radiotherapy. (2011) (11)
Differential inflammatory response dynamics in normal lung following stereotactic body radiation therapy with protons versus photons. (2019) (11)
A comparison of dose warping methods for 4D Monte Carlo dose calculations in lung (2008) (11)
TU‐C‐BRB‐08: TOPAS: A Fast and Easy to Use Tool for Particle Simulation (2011) (11)
Comparison of Particle-Tracking Features in GEANT4 and MCNPX Codes for Applications in Mapping of Proton Range Uncertainty (2011) (11)
Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors (2018) (10)
Comparing stochastic proton interactions simulated using TOPAS-nBio to experimental data from fluorescent nuclear track detectors (2017) (10)
Feasibility study of using fall‐off gradients of early and late PET scans for proton range verification (2017) (10)
CT-on-Rails Versus In-Room CBCT for Online Daily Adaptive Proton Therapy of Head-and-Neck Cancers (2021) (10)
Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy (2012) (9)
Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer (2019) (9)
A Recommendation on How to Analyze In-Room PET for In Vivo Proton Range Verification Using a Distal PET Surface Method (2015) (9)
Mechanisms and review of clinical evidence for variations in relative biological effectiveness in proton therapy. (2021) (9)
Improved efficiency in Monte Carlo simulation for passive-scattering proton therapy (2015) (9)
Flagged uniform particle splitting for variance reduction in proton and carbon ion track-structure simulations (2017) (8)
SU-E-T-473: Performance Assessment of the TOPAS Tool for Particle Simulation for Proton Therapy Applications. (2012) (8)
Advancing (proton) radiation therapy. (2013) (8)
A framework for implementation of organ effect models in TOPAS with benchmarks extended to proton therapy (2015) (8)
Monte Carlo methods for device simulations in radiation therapy (2021) (8)
In regards to hall: Intensity-modulated radiation therapy, protons, and the risk of second cancers. Authors' reply (2006) (7)
ICRP Publication 127: Radiological Protection in Ion Beam Radiotherapy. (2014) (7)
Mathematical modeling to simulate the effect of adding radiotherapy to immunotherapy and application to hepatocellular carcinoma. (2021) (7)
Proton Therapy: History and Rationale (2016) (7)
Biomathematical Optimization of Radiation Therapy in the Era of Targeted Agents. (2017) (7)
Biophysical Investigations of Therapeutic Proton Beams (1997) (7)
Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial. (2020) (7)
Attitudes of radiation oncologists toward palliative and supportive care in the United States: Report on National Membership Survey by the American Society for Radiation Oncology (ASTRO). (2016) (7)
SU‐DD‐A3‐03: Can Prompt Gamma Emission During Proton Therapy Provide in Situ Range Verification? (2009) (7)
Computing proton dose to irregularly moving targets (2014) (7)
Validation of a model for physical dose variations in irregularly moving targets treated with carbon ion beams. (2019) (7)
The probability of prompt and delayed fission of muonic237Np (1991) (7)
Fractionated Lung IMPT Treatments (2016) (7)
First results developing time-of-flight proton radiography for proton therapy applications (2019) (7)
The impact of protons on the incidence of second malignancies in radiotherapy by Eric J. Hall; Supp.31-34 2007. (2007) (7)
Roadmap: helium ion therapy (2022) (7)
SU‐GG‐J‐149: Feasibility of In‐Room PET Imaging for in Vivo Proton Beam Range Verification (2010) (6)
The Physics of Proton Biology (2011) (6)
A Monte Carlo tool for combined photon and proton treatment planning verification (2007) (6)
TOPAS-nBio validation for simulating water radiolysis and DNA damage under low-LET irradiation (2021) (6)
A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy (2022) (6)
Impact of uncertainties in range and RBE on small field proton therapy (2019) (6)
Monte Carlo Processing on a Chip (MCoaC)-preliminary experiments toward the realization of optimal-hardware for TOPAS/Geant4 to drive discovery. (2019) (6)
Predicting Organ-Specific Risk Interactions between Radiation and Chemotherapy in Secondary Cancer Survivors (2017) (6)
Limitations of analytical dose calculations for small field proton radiosurgery (2017) (6)
A MC tool for CT-based calculations of dose delivery and activation in proton therapy (2007) (6)
Feasibility of using distal endpoints for In-room PET Range Verification of Proton Therapy (2012) (6)
Assessing second cancer risk after primary cancer treatment with photon or proton radiotherapy (2020) (6)
Brain-specific RBE of Protons Based on Long-term Outcome of Patients with Nasopharyngeal Carcinoma. (2021) (6)
Modeling Resistance and Recurrence Patterns of Combined Targeted–Chemoradiotherapy Predicts Benefit of Shorter Induction Period (2019) (5)
Metal artifact reduction for radiation therapy: a simulation study (2018) (5)
Design and Testing of a Simulation Framework for Dosimetric Motion Studies Integrating an Anthropomorphic Computational Phantom into Four-dimensional Monte Carlo (2008) (5)
Study on the Effect and Mechanism of Paclitaxel-Succini Acid Drug-Loaded Nanofibers in Treating Lung Cancer. (2021) (5)
Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons. (2014) (5)
The general relation between tissue response to x-radiation (alpha/beta-values) and the relative biological effectiveness (RBE) of protons: prediction by the Katz track-structure model. (2000) (5)
The relation between microdosimetry and induction of direct damage to DNA by alpha particles (2021) (5)
Monte Carlo calculation of nanoscale dosimetric distributions of MeV proton tracks with secondary electron transport (2006) (4)
Site-Specific Range Uncertainties Due to by Dose Calculation Algorithms for Proton Therapy (2014) (4)
MO-FG-CAMPUS-IeP2-05: Feasibility Demonstration of High-Voltage Clinical CT and Impact On X-Ray Penetration Through Metal Objects. (2016) (4)
Experimental evidence for muonicX-rays from fission fragments (1993) (4)
SU‐FF‐T‐333: Monte Carlo Simulations Using Whole‐Body Pediatric and Adult Phantoms as Virtual Patients to Assess Secondary Organ Doses in Proton Radiation Therapy (2006) (4)
The Use of Computational Patient Models to Assess the Risk of Developing Radiation-Induced Cancers From Radiation Therapy of the Primary Cancer (2009) (4)
Temporal Lobe Necrosis After Proton for Nasopharyngeal Carcinoma: Predictive Factors and Clinical RBE Estimation (2017) (4)
Late Effects from Scattered and Secondary Radiation (2016) (4)
Can Robust Optimization for Range Uncertainty in Proton Therapy Act as a Surrogate for Biological Optimization (2017) (4)
Predicting In Vitro Cancer Cell Survival Based on Measurable Cell Characteristics (2019) (4)
Brain Necrosis in Adult Proton Therapy Patients. Do Necrotic Regions Have Elevated Linear Energy Transfer? (2019) (3)
Comparison of pencil-beam and Monte Carlo calculated dose distributions for proton therapy of skull-base and para-spinal tumors (2007) (3)
Patterns of Failure Following Proton Therapy in Medulloblastoma: LET Distributions and RBE Associations for Relapses (2014) (3)
Beam Delivery Using Passive Scattering ............................................... Roelf Slopsema (2016) (3)
Comparing 2 Monte Carlo Systems in Use for Proton Therapy Research. (2019) (3)
Radiological protection in ion beam radiotherapy: practical guidance for clinical use of new technology (2016) (3)
Preliminary Study of Proton Radiography Imaging Qualities Using GEANT4 Monte Carlo Simulations (2011) (3)
Modeling RBE-weighted dose variations in irregularly moving abdominal targets treated with carbon ion beams. (2020) (3)
Time‐resolved diode dosimetry calibration through Monte Carlo modeling for in vivo passive scattered proton therapy range verification (2017) (3)
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC. (2021) (3)
Simulation of four-dimensional effects in radiation therapy: the dose in intensity modulated beam delivery under organ motion (2003) (3)
OC-0245: Clinical evidence that end-of-range proton RBE exceeds 1.1: lung density changes following chest RT (2017) (3)
The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma (2021) (3)
When Does Pencil Beam Scanning Improve the Treatment Outcome of Pediatric Head-and-Neck/CNS Patients Over Passive Scattered Proton Therapy? (2013) (2)
TU‐F‐CAMPUS‐T‐04: Using Gold Nanoparticles to Target Mitochondria in Radiation Therapy (2015) (2)
SU‐E‐T‐639: Proton Dose Calculation for Irregular Motion Using a Sliding Interface (2015) (2)
SU-E-T-258: Assessment of Radiation Induced Second Cancer Risks in Proton Therapy and IMRT for Organs inside the Main Radiation Field. (2012) (2)
First in-room PET studies for range verification of proton therapy (2010) (2)
SU-F-T-206: Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for LET and Dose/Volume Parameters for the Brainstem and Organs at Risk. (2016) (2)
SU-E-T-500: Pencil-Beam versus Monte Carlo Based Dose Calculation for Proton Therapy Patients with Complex Geometries. Clinical Use of the TOPAS Monte Carlo System. (2012) (2)
SU‐GG‐AUD‐10: Quantitative Assessment of the Accuracy of Proton Beam Range Verification with PET/CT (2007) (2)
Integrating Structure Propagation Uncertainties in the Optimization of Online Adaptive Proton Therapy Plans (2022) (2)
MOQUI: an open-source GPU-based Monte Carlo code for proton dose calculation with efficient data structure (2022) (2)
Clinical validation of an analytical procedure for in vivo PET range verification in proton therapy (2009) (2)
SU‐E‐T‐135: Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy (2015) (2)
TU-C-T-617-10: The Use of a Miniature Multileaf Collimator in Stereotactic Proton Therapy (2005) (2)
Why Is Proton Beam Therapy So Controversial? (2015) (2)
WE-F-105-03: Development of GPMC V2.0, a GPU-Based Monte Carlo Dose Calculation Package for Proton Radiotherapy. (2013) (2)
Detector Simulation Challenges for Future Accelerator Experiments (2022) (2)
Physics of Treatment Planning for Single-Field Uniform Dose (2011) (2)
Proton Monte Carlo in the clinic (2006) (2)
Impact of DNA Geometry and Scoring on Monte Carlo Track-Structure Simulations of Initial Radiation-Induced Damage (2022) (2)
DICOM-RT Ion interface to utilize MC simulations in routine clinical workflow for proton pencil beam radiotherapy. (2020) (2)
SU-E-T-375: Passive Scattering to Pencil-Beam-Scanning Comparison for Medulloblastoma Proton Therapy: LET Distributions and Radiobiological Implications. (2014) (2)
PET/CT Treatment Verification after Proton Therapy in Abdominopelvic Tumor Sites (2008) (2)
Evaluating Intensity Modulated Proton Therapy relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in CSI in Growing Pediatric Patients (2017) (2)
SU-F-T-139: Meeting the Challenges of Quality Control in the TOPAS Monte Carlo Simulation Toolkit for Proton Therapy. (2016) (2)
The impact of variable relative biological effectiveness in proton therapy for left-sided breast cancer when estimating normal tissue complications in the heart and lung (2020) (2)
The study of prompt and delayed muon induced fission (1993) (2)
SU‐GG‐T‐413: Comparison of Out‐Of‐Field Neutron Equivalent Doses in Scanning Carbon and Proton Therapies for Cranial Fields (2010) (2)
SU‐FF‐T‐205: Effects of Intra‐Fraction Motion On IMRT Treatment with Segments of Few Monitor Units (2006) (2)
TU-A-108-02: A 4D Monte Carlo Study Quantifying Changes in the Interplay Effect as a Function of Treatment Delivery Parameters in Proton Beam Scanning for Lung. (2013) (2)
Foreword: Hadron Therapy – From Yesterday's Physics Laboratory to Today's Modern Clinical Routine (2003) (2)
WE‐C‐BRB‐07: Benchmarking of the TOPAS Monte Carlo System against Phantom Dose Measurements in Proton Therapy (2012) (2)
TH‐A‐BRD‐01: The Future of NIH Research Funding (2009) (2)
Complexity-weighted doses reduce biological uncertainty in proton radiotherapy planning (2018) (2)
WE-G-500-04: A Novel Technique for In-Vivo and Real-Time Range Verification Based On the Characteristic Prompt Gamma Time-Structure of Passively Modulated Proton Beams. (2013) (2)
Estimated Risk for a Second Malignancy after Proton and Photon Radiation Therapy for Breast Cancer (2019) (1)
Dose-rate effects when estimating risks for second malignancies: in regard to Fontenot et al (Int J Radiat Oncol Biol Phys 2009;74:616-622). (2009) (1)
Late-Phase Radiographic Changes in Lung Following Proton Irradiation of the Chest Wall (2016) (1)
Author Correction: Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model (2018) (1)
LET-Based Inverse Planning for IMPT (2015) (1)
SU‐GG‐T‐338: Recent Improvements in the Geant4 Monte Carlo Simulation Toolkit for Medical Physics Applications (2008) (1)
TH‐C‐BRB‐04: Reliability of Proton‐Nuclear Interaction Cross Section Data to Predict Proton‐Induced PET Images in Proton Therapy (2011) (1)
Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation (2014) (1)
Effects of Gold Nanoparticles for Radiation Therapy Enhancement (2015) (1)
A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals (2022) (1)
SU-E-T-180: Fano Cavity Test of Proton Transport in Monte Carlo Codes Running On GPU and Xeon Phi. (2014) (1)
Digital Holographic Microscopy for Nanoscale Dose Calculation and Assessing Gold Nanoparticle Uptake in Live Cells. (2016) (1)
TU-A-108-10: Pencil Beam Scanning Vs. Passive Scattered Proton Therapy for Pediatric Thoracic/pelvic Cancers. (2013) (1)
National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States (2022) (1)
SU-G-TeP1-06: Fast GPU Framework for Four-Dimensional Monte Carlo in Adaptive Intensity Modulated Proton Therapy (IMPT) for Mobile Tumors. (2016) (1)
EP-1587 CELL SURVIVAL RESPONSES TO MODULATED PROTON BEAMS DELIVERED BY PASSIVE SCATTERING AND PENCIL BEAM SCANNING (2012) (1)
MO-F-213AB-03: Potential Reduction in Out-Of-Field Dose in Pencil Beam Scanning Proton Therapy Through Use of a Patient-Specific Aperture. (2012) (1)
Dosimetric Uncertainties and Their Impact on Treatment Planning in Stereotactic Proton Radiosurgery (2016) (1)
SU-F-T-132: Variable RBE Models Predict Possible Underestimation of Vaginal Dose for Anal Cancer Patients Treated Using Single-Field Proton Treatments. (2016) (1)
Feasibility of Using Distal Endpoints for In-Room PET Range Verification of Proton Therapy (2013) (1)
TU‐EF‐304‐08: LET‐Based Inverse Planning for IMPT (2015) (1)
Delayed muon induced fission of209Bi and the role of meson-exchange currents (1992) (1)
SU-E-T-552: Maximizing the Biological Effect of Proton Dose Delivered with Scanned Beam. (2012) (1)
Dose Calculation Algorithms * (2016) (1)
SU-GG-T-317: Impact of Tumor Motion and Size in the Irradiation of Moving Tumors in Step-And-Shoot IMRT: A NCAT Based 4D Monte Carlo Simulation Study (2008) (1)
Protons: Clinical Considerations and Applications (2016) (1)
Proton Therapy (2018) (1)
Low-Dose Computed Tomography Scanning Protocols for Online Adaptive Proton Therapy of Head-and-Neck Cancers (2022) (1)
SU‐FF‐J‐129: In‐Room Proton Range Verification Using Mobile NeuroPET ‐ Feasibility Study (2009) (1)
Adjuvant radiation therapy for early-stage seminoma: Proton-photon comparison and second cancer risk. (2011) (1)
TH-C-213CD-01: Accuracy of Proton Dose Computation Algorithms and Need for Improvements (2012) (1)
SU‐GG‐T‐357: Geant4 Benchmarking for IMRT Dose Calculations (2008) (1)
TOPAS-nBio: A Monte Carlo simulation toolkit for cell-scale radiation effects (2019) (1)
TH-D-303A-03: Validation of An Analytical 1D Filtering of the Dose Distribution for the Calculation of the Expected PET Distributions in Proton Therapy. (2009) (1)
Applications to Secondary Radiation Dosimetry in External Beam Radiation Therapy (2009) (1)
Proton vs. photon radiotherapy for MR-guided dose escalation of intraprostatic lesions (2021) (1)
REPRESENTING RANGE COMPENSATORS IN THE TOPAS MONTE CARLO SYSTEM (2012) (1)
Correction: Dependence of gold nanoparticle radiosensitization on cell geometry. (2017) (1)
Monte Carlo Simulations * (2011) (1)
The impact of variable relative biological effectiveness in proton therapy for left-sided breast cancer when estimating normal tissue complications in the heart and lung. (2021) (1)
SU‐FF‐T‐408: The IAEA Initiative to Standardize Nuclear Data for Heavy Charged‐Particle Radiotherapy (2007) (1)
Advanced Dose Calculation to Reduce Uncertainties in Treatment Planning and Delivery for Proton Therapy Patients (2012) (1)
Dose Response Relationship for Permanent Alopecia in Pediatric Medulloblastoma Patients Treated With Proton Radiation Therapy (2012) (1)
SU-E-T-464: On the Equivalence of the Quality Correction Factor for Pencil Beam Scanning Proton Therapy. (2014) (1)
Design Considerations for Intensity Modulated Proton Therapy Treatment Planning (2000) (1)
SU-FF-T-405: Dose to Water Versus Dose to Medium in Proton Beam Therapy (2009) (1)
SU-F-BRD-15: Quality Correction Factors in Scanned Or Broad Proton Therapy Beams Are Indistinguishable (2015) (1)
A Geometric Knowledge-Based Model to Quickly Predict the Patient-Specific Benefits of Proton Therapy in Clival Chordoma Patients (2016) (1)
Monte carlo calculations in support of the commissioning of the Northeast Proton Therapy Center (2003) (1)
TU‐E‐BRB‐05: Streamlining Monte Carlo Dose Calculations for Routing Clinical Use in Proton Therapy (2011) (1)
TU‐FF‐A1‐01: Quantification of Clinical Limitations of Proton Beam Range Verification Using Offline PET/CT Due to Biological Washout Effects (2008) (1)
SU-FF-T-347: Proton Dose Calculation Using Monte-Carlo-Validated Pencil Beam Database for KonRad Treatment Planning System (2005) (1)
TU‐C‐M100J‐05: Image Guided 4D Monte Carlo Study of the Dosimetric Effects of Intra/inter Fraction Motion in Lung Tumors (2007) (1)
SU-F-BRD-12: When Does Pencil Beam Scanning Become Superior to Passive Scattered Proton Therapy for Pediatric Head and Neck Cancers? (2015) (1)
Introduction and History of Proton Therapy (2015) (1)
Lifetime Risk for Developing a Second Malignancy in the High/Medium-Dose Region for Pediatric Patients for Different Radiation Therapy Modalities (2011) (1)
TH‐C‐BRB‐06: Comparison of Prompt Gamma and PET Imaging for Range Verification in Proton Therapy (2011) (1)
Effects of Excess Breathing Motion on Proton Dose Coverage (2015) (1)
SU‐E‐T‐518: Investigation of Gold Nanoparticle Radiosensitization for Carbon Ion Therapy (2015) (1)
TH‐C‐BRB‐06: Comparison of Prompt Gamma and PET Imaging for Range Verification in Proton Therapy (2011) (1)
The Risk of Developing a Neutron-induced Second Malignancy for Pediatric Proton Therapy Patients (2008) (1)
SU-FF-T-181: Dosimetric Uncertainties in IMRT QA in Plastic Phantoms Due to CT Calibration (2007) (0)
TU-EF-304-12: Proton Radiation Therapy for Left-Sided Breast Cancer: LET and RBE Considerations for Cardiac Toxicity (2015) (0)
Validation of nuclear models in Geant4 using the halo of a proton pencil beam stopping in water (2015) (0)
SU-E-T-495: Monte Carlo Dose Verification of Passive Scattering Proton Therapy for Prostate Cancer. (2012) (0)
SU-FF-J-44: PET/CT Imaging for 3D In-Vivo Treatment Verification in ProtonTherapy — a Feasibility Study (2005) (0)
2874 : Clinical Feasibility of PET/CT Image Guidance After Proton Radiotherapy (2006) (0)
SU‐E‐T‐673: Recent Developments and Comprehensive Validations of a GPU‐Based Proton Monte Carlo Simulation Package, GPMC (2015) (0)
TH-C-144-03: Tissue Decomposition From Dual Energy CT Data to Reduce Range Uncertainties in Proton and Carbon Radiotherapy. (2013) (0)
TOPAS-imaging: extensions to the TOPAS simulation toolkit for medical imaging systems (2023) (0)
TU-A-108-08: Comparison of Full Intensity Modulated and Single Field Uniform Dose Proton Beam Scanning Lung Treatments. (2013) (0)
The use of Monte Carlo methods in heavy charged particle radiation therapy. (2007) (0)
WE‐C‐BRB‐09: Development of a GPU‐Based Monte Carlo Dose Calculation Package for Proton Radiotherapy (2012) (0)
SU‐FF‐T‐341: Energy Distributions of Proton Interactions in MCNPX and GEANT4 Codes Using a Slab Target (2005) (0)
Author Correction: Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model (2018) (0)
SU-GG-T-434: A Joint Research Investigation Comparing MCNPX and Geant4 Monte Carlo Codes to Reduce the Range Uncertainties in Proton Therapy (2010) (0)
WE-C-AUD-05: Simulation of Neutron Dose Exposure for Pediatric Proton Therapy Patients Using Whole-Body Age-Dependent Voxel Phantoms (2007) (0)
TU‐G‐BRA‐01: Clinical Significance of RBE Variations in Proton and Carbon Ion Therapy (an Overview/introduction to the Problem) (2011) (0)
WE‐C‐AUD‐01: Differences in Predicted Beam Range, Lateral Scatter and Absolute Dose Between Proton Monte Carlo and Pencil‐Beam Dose Calculation Considering Single Fields and Full Plans for Head and Neck Tumors (2007) (0)
Brain-specific End-of-range RBE Based on Long-term Follow-up of Patients with Nasopharyngeal Carcinoma (2019) (0)
SU-E-T-466: Implementation of An Extension Module for Dose Response Models in the TOPAS Monte Carlo Toolkit (2015) (0)
Pre- and post-treatment image-based dosimetry in 90Y-microsphere radioembolization using the TOPAS Monte Carlo toolkit (2021) (0)
Introduction and a Word of Thanks (2012) (0)
TH-A-19A-02: Expanding TOPAS Towards Biological Modeling. (2014) (0)
Poster ViewingComparison of Internal Tumor Volume Definition Strategies to Reduce Plan Degradation of Intensity Modulated Proton Therapy Plans for Mobile Lung Tumor (2017) (0)
MO‐SAM‐BRB‐01: Biological Aspects of Heavy Charged Particle Radiation Therapy (2009) (0)
SU-E-T-292: Sensitivity of Fractionated Lung IMPT Treatments to Setup Uncertainties and Motion Effects. (2014) (0)
MO-G-137-02: Experimental Validation of Clinical as Well as Monte Carlo Dose Calculation for Proton Therapy of Lung Cancer Patients. (2013) (0)
Anatomic Changes in Head and Neck Intensity-modulated Proton Therapy: Comparison between Robust Optimization and Daily Adaptation (2020) (0)
SU‐GG‐T‐432: Implementation of Modular Phase Space IO in Geant4 with Enhanced Latch Capability (2010) (0)
SU-E-J-247: Time Evolution of Radiation-Induced Lung Injury After Stereotactic Proton Therapy (2015) (0)
Spatiotemporal optimisation of prostate intensity modulated proton therapy (IMPT) treatments (2022) (0)
TU‐EF‐304‐05: Anterior Proton Beams for Prostate Treatments Lead to Substantial Elevations in Modeled RBE‐Weighted Rectal Dose (2015) (0)
Effects of intra-fraction motion on IMRT treatments with low monitor unit segments (2007) (0)
Radiation Therapy for Stage IIA/B Seminoma: Modeling Secondary Cancer Risk for Protons and VMAT vs. 3D Photons (2022) (0)
SU‐FF‐T‐442: Comparing Geant4 and MCNPX for Joint Research to Minimize Uncertainties in Proton Therapy (2009) (0)
Dynamics of Tumor Subpopulations in Response to Targeted Therapies (2019) (0)
Comparing pencil-beam generated and Monte Carlo generated dose-to-water and dose-to-tissue distributions for proton therapy patients (2009) (0)
Quantification of Clinical Limitations of Proton Beam Range Verification Using Onine PET/CT Due to Biological Washout Effects (2008) (0)
WE-FG-BRB-01: Clinical Significance of RBE Variations in Proton Therapy. (2016) (0)
TU-A-BRE-01: The Relative Biological Effectiveness of Proton Beams Relative to Photon Beams. (2014) (0)
SP-0223: Latest developments in in-vivo dose and range imaging (2014) (0)
WE-H-BRA-07: Mechanistic Modelling of the Relative Biological Effectiveness of Heavy Charged Particles. (2016) (0)
Characterisation of proton pencil beam scanning and passive 1 beam using a high spatial resolution solid state microdosimeter 2 (2018) (0)
New Range Margin Recommendations Based on Dose Calculation Uncertainties (2018) (0)
SU‐FF‐T‐331: Optimization of the Beam Width in a Universal Proton Therapy Nozzle (2007) (0)
Predicting the benefits of proton therapy in lung cancer patients from patient-specific anatomic and pathologic geometry (2017) (0)
SU‐GG‐T‐327: Simulation of Neutron Equivalent Doses in Proton Therapy as a Function of Patient's Age for Different Tumor Sites (2008) (0)
Delayed muon induced fission of 2 ~ and the role of meson-exchange currents (0)
TH-CD-209-09: Quickly Identifying Good Candidates for Proton Therapy From Geometric Considerations. (2016) (0)
Dose Calculations in Radiation Therapy Based on Patient Models Using the Geant4 Monte Carlo Code (2009) (0)
NCI Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury (2018) (0)
OC-0268: Uncertainties in PET-based range verification of pristine and spread-out Bragg peaks of clinical proton therapy (2014) (0)
Poster — Thur Eve — 64: A Water Calorimetry‐Based Dosimetry Standard for Direct Measurement of Absolute Absorbed Dose in Scanning Proton Beam Delivery (2010) (0)
Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4D Blood Flow Simulations. (2023) (0)
Dose Rate Effects on Tumor Cell Response to Intensity Modulated Fractionated Radiation Therapy (2005) (0)
Elevated Proton Radiation Therapy Dose to Left Temporal Lobe or Whole-Brain Correlates With Decline in Full-Scale IQ Components for Pediatric CNS Tumor Survivors (2016) (0)
TU‐C‐BRA‐04: Should We Worry About Neutrons? (2007) (0)
SU‐FF‐T‐430: Comparison of Dose Volume Histograms From Selected Proton Therapy Treatments Between Geant4.5.0 and Geant4.9.0 Monte Carlo Simulations with and Without Dynamic Densities (2009) (0)
SU-E-T-369: Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in CSI of Pediatric Patients (2015) (0)
Out of Field Cancer Risk in Mice Following Exposure to a Clinical Proton Beam (2012) (0)
SU-E-T-524: In-Vivo Diode Dosimetry Proton Therapy Range Verification Validation Study for Pediatric CSI (2015) (0)
A CASE STUDY ON PATIENT EFFECTIVE DOSES DURING PROTON RADIATION TREATMENT (2005) (0)
SU-E-T-324: The Influence of Patient Positioning Uncertainties in Proton Radiotherapy On Proton Range and Dose Distributions. (2014) (0)
The Physics of Proton Biology * (2018) (0)
Validation and optimization of in-room PET for proton range verification (2011) (0)
SU-DD-A2-02: Repair Kinetic Considerations in High-LET Particle Beam Radiotherapy (2010) (0)
MO-A-213AB-08: 2D Water Equivalent Path Length Imaging Technique for Pre-Treatment Range Verification in Proton Therapy. (2012) (0)
Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton vs Photon Therapy in Hepatocellular Carcinoma. (2023) (0)
TH-D-BRC-03: Panel Member. (2016) (0)
WE-G-BRE-02: Biological Modeling of Gold Nanoparticle Radiosensitization for Proton Therapy. (2014) (0)
MO‐E‐BRB‐02: Biologically Optimized Treatment Planning for Proton Therapy: Monte Carlo Calculated Linear Energy Transfer Distributions in Patients (2010) (0)
SU-G-TeP4-04: An Automated Monte Carlo Based QA Framework for Pencil Beam Scanning Treatments. (2016) (0)
Monte Carlo methods for medical physics : a practical introduction (2018) (0)
SU‐FF‐J‐92: Dosimetric Impact of Motion Mitigation Strategies in the Irradiation of Moving Tumors: A 4D Monte Carlo Simulation Study (2007) (0)
SU‐FF‐J‐126: Study of the Variability of the Dosimetric Outcome Produced by Patient Organ‐Movement and Dynamic MLC Delivery with Focus On Intra‐Fraction Effects (2009) (0)
Quantitative assessment of the reproducibility and the consistency of proton beam range verification with PET/CT (2008) (0)
Symptomatic Treatment Change in Medulloblastoma Patients After Proton RT: LET Distributions and RBE Associations (2014) (0)
SU‐GG‐I‐110: Study of the Use of Protons and Carbon Ions for Patient Imaging (2008) (0)
SU‐GG‐T‐501: Dosimetric Effects Caused by Interplay Between MLC‐Delivery Dynamics and Organ Breathing‐Motion in IMRT for Lung (2008) (0)
WE‐C‐BRB‐06: Clinical Impact of Uncertainties in the Mean Excitation Energy of Human Tissues during Proton Therapy (2012) (0)
TH-CD-209-06: LET-Based Adjustment of IMPT Plans Using Prioritized Optimization. (2016) (0)
LET Versus Dose-Sparing of the Brainstem in Proton Radiation Therapy: Treatment Technique Comparison for Posterior Fossa Tumors Based on Variable RBE (2015) (0)
In Vivo Treatment Verification Using In-room PET in Proton Radiation Therapy: First Clinical Trials and Evaluation of Short-length Scan (2012) (0)
SU-E-J-158: Experimental Investigation of Proton Radiography Based On Time-Resolved Dose Measurements. (2014) (0)
TU-A-108-01: Four-Dimensional Monte Carlo Using the TOPAS TOol for PArticle Simulation. (2013) (0)
SU‐FF‐T‐157: Different Methods of Organ Equivalent Dose Scoring in Monte Carlo Neutron Dose Calculations (2007) (0)
Parathyroid Hormone Reduces Persistent Proton Induced DNA Double-Strand Breaks in Osteocytes (2022) (0)
WE-G-BRE-04: Gold Nanoparticle Induced Vasculature Damage for Proton Therapy: Monte Carlo Simulation. (2014) (0)
Introduction (2018) (0)
SU-GG-T-340: A Comparison of Geant4 and DPM for 4D Monte Carlo of Lung IMRT (2008) (0)
SU-E-T-451: Patient and Site-Specific Assessment of the Value of Routine Monte Carlo Dose Calculation in Proton Therapy. (2013) (0)
TH‐E‐BRA‐06: Feasibility of Real Time MRI‐Guidance in Proton Therapy (2012) (0)
Quantitative Evaluation of Normal Lung Density Changes in Non-Small Cell Lung Cancer Patients Treated With Radiotherapy and PD-1 Immune Checkpoint Inhibitors. (2021) (0)
"Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties" by Raptis et al. (Physica Medica 76 (2020) 1-6). (2020) (0)
SP-0111: Dose calculation accuracy in proton therapy (2015) (0)
TH-A-19A-03: Impact of Proton Dose Calculation Method On Delivered Dose to Lung Tumors: Experiments in Thorax Phantom and Planning Study in Patient Cohort. (2014) (0)
WE-C-224A-05: Patient Modeling and Organ Dose Calculations Using Monte Carlo Methods (2006) (0)
Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions (2023) (0)
TH‐C‐AUD‐06: Breathing Interplay Effects During Proton Beam Spot Scanning: Simulation and Statistical Analysis (2007) (0)
TU-G-BRCD-02: Do Uncertainties in Proton Therapy Limit Its Clinical Potential? (2012) (0)
TH-A-19A-06: Site-Specific Comparison of Analytical and Monte Carlo Based Dose Calculations. (2014) (0)
MO‐E‐BRA‐04: In‐Field Risk of Radiation Induced Second Cancer in Proton Therapy and IMRT for Pediatric Patients Considering Dose Inhomogeneities (2010) (0)
Proton Therapy and the Role of Dosimetric Parameters as Predictors for Normal Tissue Complications after Liver-Directed Stereotactic Body Radiation Therapy (2018) (0)
Linear energy transfer ( LET )-Guided Optimization in intensity modulated proton therapy ( IMPT ) : feasibility study and clinical potential (2015) (0)
Optimizing the Administration of Tyrosine Kinase Inhibitors with Chemoradiotherapy to Improve Outcomes in Locally Advanced, EGFR+ NSCLC Using an Evolutionary Tumor Progression Model (2019) (0)
Novel in-room proton range verification using mobile PET: Potential for proton therapy monitoring (2009) (0)
Principles and Parctice of Proton Beam Therapy (2015) (0)
MO‐E‐T‐617‐07: Simulation of Organ Specific Secondary Neutron Dose in Proton Beam Treatments (2005) (0)
TH-C-213AB-11: LET-Guided Biological Optimization in IMPT (2012) (0)
WE-H-BRA-04: Biological Geometries for the Monte Carlo Simulation Toolkit TOPASNBio. (2016) (0)
Protons for Prostate: Seeking Benefit via Anterior Beam Angles (2015) (0)
SU-FF-T-339: Comparison of Pencil Beam Algorithm and Monte Carlo Dose Calculation for Proton Therapy of Paranasal Sinus Cancer (2005) (0)
Four-dimensional Blood Flow Model for Dose Calculation to Circulating Blood and Lymphocytes (2021) (0)
SU‐GG‐J‐79: Experimentally Optimizing Prompt Gamma Detection for Proton Therapy (2010) (0)
SU-F-T-157: Physics Considerations Regarding Dosimetric Accuracy of Analytical Dose Calculations for Small Field Proton Therapy: A Monte Carlo Study. (2016) (0)
Predicting Secondary Breast and Lung Malignancy Risk After Combined Chemoradiation Treatment (2015) (0)
SU‐FF‐T‐439: Dynamic Monte Carlo Dose Calculations for IMRT in Geant4 (2009) (0)
High Dose Rate and Fractionation to Reduce Radiation-Induced Lymphopenia: In Vivo Derivation of Lymphocyte Radiosensitivity Using Patient-Specific Blood Flow Simulations (2022) (0)
TH-AB-304-10: Modeling Organ Specific Mechanistic Interactions Between Radiation and Chemotherapy (2015) (0)
WE-AB-207B-06: Dose and Biological Uncertainties in Sarcoma. (2016) (0)
MO-D-ValA-03: Inverse Planning Optimization with Organ Motion Probability (2006) (0)
SU‐FF‐T‐137: Design of a Vacuum Chamber for a Universal Proton Therapy Nozzle (2007) (0)
SU‐GG‐T‐418: Comparing Computational Phantoms and Whole‐Body Patient CT Images for Secondary Cancer Risk Estimation (2010) (0)
SP-0209: Should proton therapy clinical practice move away from a constant RBE of 1.1? (2018) (0)
TU-D-224A-05: Dose-Guided Particle Therapy with PET Imaging (2006) (0)
Assessment of out-of-ﬁeld absorbed dose and equivalent dose in proton ﬁelds (2009) (0)
Fast Monte Carlo Dose Calculation on GPU for Proton Therapy (2012) (0)
Comparison of HETC and PTRAN with phantom measurement data (1997) (0)
WE-A-WAB-01: New Technologies Addressing the Range Uncertainty of Proton Therapy. (2013) (0)
WE-H-BRA-03: Development of a Model to Include the Evolution of Resistant Tumor Subpopulations Into the Treatment Optimization Process for Schedules Involving Targeted Agents in Chemoradiation Therapy. (2016) (0)
TH-CD-201-07: Experimentally Investigating Proton Energy Deposition On the Microscopic Scale Using Fluorescence Nuclear Track Detectors. (2016) (0)
SU‐E‐T‐752: Three‐Dimensional Carcinogenic Maps Induced by Photons and Protons (2015) (0)
TH‐D‐ValA‐07: Clinical Use of Monte Carlo in Proton Therapy: Pencil‐Beam Algorithm Vs Monte Carlo for Proton Therapy of Skull‐Base and Para‐Spinal Tumors (2006) (0)
An Increased Rib Fracture Rate in Patients Receiving Proton Therapy for Breast Cancer is Correlated with the End-of-range Radiobiological Effect (2019) (0)
Clinical implementation of proton Monte Carlo dose calculation. (2005) (0)
Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model (2017) (0)
MO-FG-BRA-06: Material Optimisation for Nanoparticle-Sensitized Radiotherapy (2015) (0)
SU‐E‐T‐512: Monte Carlo Dose Verification of Pencil Beam Scanning Proton Therapy (2013) (0)
Hydrogel rectum-prostate spacers and anterior-oblique proton beams ” (2017) (0)
WE‐C‐BRC‐01: In Vivo Proton Beam Range Verification Using Spine MRI Changes (2009) (0)
TH‐C‐BRB‐08: Four‐Dimensional Monte Carlo Simulations of Lung Cancer Patients Treated with Proton Beam Scanning to Assess Interplay Effects (2012) (0)
Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy (2022) (0)
Treatment planning in 3 and 4 dimensions and the role of Monte Carlo techniques (2007) (0)
WE-FG-202-03: Quantitative CT-Based Analysis to Assess Lung Injury Following Proton Radiotherapy. (2016) (0)
A general mechanistic model enables predictions of the biological effectiveness of different qualities of radiation (2017) (0)
Hematologic Toxicities During Treatment Allow for Improved Prediction of Recurrences in Pediatric Medulloblastoma (2017) (0)
SP-0671 The clinical impact of a variable RBE (2021) (0)
SU‐GG‐T‐295: Determination of the Dose Equivalent Near Proton Pencil Beams (2008) (0)
SU-F-500-04: Motion Mitigation in Active Scanning Proton Therapy for Lung Cancer: A 4D Monte Carlo Study. (2013) (0)
Prediction of Hepatic Toxicity after Radiotherapy Using a Neural Network Including Blood Biomarkers and Liver Dose Distributions (2022) (0)
TH‐E‐BRC‐02: Comparison of Organ Doses in Pediatric Phantoms for Secondary Cancer Risk Assessment in Proton Radiotherapy (2011) (0)
Erratum: Evaluation of CBCT scatter correction using deep convolutional neural networks for head and neck adaptive proton therapy (2020 Phys. Med. Biol. 65 245022) (2021) (0)
PO-1564 CT on rails versus in-room CBCT for online daily adaptive proton therapy (2021) (0)
OC-0437: An algorithm to assess the need for clinical Monte Carlo dose calculations for proton therapy fields (2013) (0)
Image-Based Modeling of EGFR TKI Resistance Development and Possible Applications to Optimizing Induction Regimen in Stage III Nonsmall Cell Lung Cancer (2017) (0)
WE-D-BRF-01: FEATURED PRESENTATION - Investigating Particle Track Structures Using Fluorescent Nuclear Track Detectors and Monte Carlo Simulations. (2014) (0)
Breathing interplay effects during proton radiation therapy and development of repainting solutions (2006) (0)
Dynamic Hepatic Blood Flow Model Shows Greater Impact of Total Treatment Time Than Integral Dose for Assessing Dose to Circulating Lymphocytes. (2021) (0)
OC-0079: Biological modeling of gold nanoparticle radiosensitization for proton therapy (2014) (0)
2883: Assessment of the Relative Biological Effectiveness of Clinical Carbon Ion Beams (2006) (0)
Poster ‐ 16: Time‐resolved diode dosimetry for in vivo proton therapy range verification: calibration through numerical modeling (2016) (0)
Cardiac Toxicity From Proton Radiation Therapy of Left-Sided Breast Cancer: LET and RBE Considerations (2016) (0)
SU-E-T-554: Monte Carlo Calculation of Source Terms and Attenuation Lengths for Neutrons Produced by 50–200 MeV Protons On Brass (2015) (0)
WE-C-108-07: Optimal Parameters for Variance Reduction in Monte Carlo Simulations for Proton Therapy. (2013) (0)
MO-B-AUD C-01: Proton Therapy (2008) (0)
SU-E-T-124: Assessing Quality Assurance of Proton Scattering Nozzles Using Monte Carlo. (2013) (0)
TU‐A‐224‐01: Practical Research Advice: NIH Navigation and Grantsmanship (2011) (0)
SU-E-T-616: Comparison of Plan Dose Accuracy for Anterior Vs. Lateral Fields in Proton Therapy of Prostate Cancer. (2014) (0)
TU-A-108-06: Computing Proton Dose to Irregularly Moving Targets. (2013) (0)
TH-A-116-02: Radiobiological Implications of Various Target and Beam Geometry Utilization in Treatment Planning for Intensity Modulated Proton Therapy. (2013) (0)
WE-E-116-01: Grantsmanship and Funding. (2013) (0)
PO-0888: Evaluation of 6 proton dose calculation algorithms using a critical experimental phantom (2015) (0)
MO-F-BRB-03: A Method to Assess the Need for Clinical Monte Carlo Dose Calculations for Small Proton Therapy Fields. (2012) (0)
MO-A-213AB-07: Evaluation of Distal Dose Surface with In-Room PET for Proton Therapy Monitoring. (2012) (0)
TH‐D‐BRB‐07: Improving Computational Efficiency in Monte Carlo Simulations of a Passive Scattering Proton Therapy Treatment Head (2010) (0)
Simulating Dose and Cancer Risk due to Low-Dose Neutron Background in Proton Beam Therapy (2009) (0)
SU-E-T-470: Comparison of Proton Treatment Planning and Monte Carlo Calculation Using TOPAS for Liver Cancer. (2012) (0)
Large anatomical changes in head-and-neck cancers - A dosimetric comparison of online and offline adaptive proton therapy. (2023) (0)
LET Guided Biological Optimization in IMPT: Implications on RBE Value (2012) (0)
PD-0096: Quantification of gold nanoparticle induced microscopic dose enhancement using protons (2014) (0)
SU‐E‐T‐694: Evaluating Pencil Beam Dose Algorithm in Lung with Monte Carlo (2011) (0)
SU‐FF‐J‐124: The Effects of Anatomy Motion On Dose Distribution (2007) (0)
TU‐G‐BRB‐02: Comprehensive Handling of Time‐Dependent Quantities in Scanning Beam Simulation (2011) (0)
SU-E-T-478: Geometrical Splitting Technique to Improve the Computational Efficiency in Monte Carlo Calculations for Proton Therapy. (2012) (0)
Practical Radiobiology for Proton Therapy Planning (2017) (0)
SU‐E‐T‐272: In‐Vivo Proton Dose Reconstruction from PET Images (2011) (0)
SU‐EE‐A2‐01: Direct Measurement of Absolute Absorbed Dose in Scanning Proton Beams Based on Water Calorimetry (2010) (0)
Prediction of Outcomes after Radiotherapy for Hepatocellular Carcinoma Independently Validated Using Multi-Institutional Data. (2021) (0)
SU‐E‐T‐22: A Deterministic Solver of the Boltzmann‐Fokker‐Planck Equation for Dose Calculation (2015) (0)
A Computational Approach to Multimodal Treatment Stratification in EGFRmut NSCLC: How Does Pre-Treatment TKI Resistance Affect Outcomes and Optimal Treatment Schedule? (2020) (0)
Tumor-Specific Modeling of Chemotherapy Combined With Radiation in Stage III NSCLC Suggests Novel Patient Stratification Criteria for Therapy Sequencing (2017) (0)
HERMAN D. SUIT, MD, DPhil1929–2022A Giant of Modern Radiation Oncology (2022) (0)
EP-2332: A concept to personalize radiation oncology: Predicting cell-specific survival prior to treatment (2018) (0)
SU-E-T-769: T-Test Based Prior Error Estimate and Stopping Criterion for Monte Carlo Dose Calculation in Proton Therapy (2015) (0)
TU‐C‐BRA‐03: The Good and the Not‐So‐Good of the Finite Proton Range (2007) (0)
TU-F-CAMPUS-T-02: Risk Assessment of Scattered Neutrons for a Fetus From Proton Therapy of a Brain Tumor During Pregnancy (2015) (0)
TU-F-CAMPUS-T-02: Risk Assessment of Scattered Neutrons for a Fetus From Proton Therapy of a Brain Tumor During Pregnancy (2015) (0)
SU‐E‐T‐05: Biophysical Modeling Intercomparison of Proton Radiation Effectiveness (2011) (0)
TU-F-CAMPUS-T-02: Risk Assessment of Scattered Neutrons for a Fetus From Proton Therapy of a Brain Tumor During Pregnancy (2015) (0)
SU-FF-T-409: Simulation of the Risk of Developing a Second Cancer Due to the Scattered Radiation for Different Treatment Modalities at Different Sites (2009) (0)
SU-E-T-404: Quantification of Proton Dose Enhancement Resulting From Gold Nanoparticles. (2013) (0)
SU-E-T-567: Neutron Dose Equivalent Evaluation for Pencil Beam Scanning Proton Therapy with Apertures (2015) (0)
PO-0874: Proton therapy range verification accuracy considering range mixing for time resolved dosimetry (2018) (0)
In vivo verification of proton beam delivery by PET-CT (2007) (0)
TH-A-19A-11: Validation of GPU-Based Monte Carlo Code (gPMC) Versus Fully Implemented Monte Carlo Code (TOPAS) for Proton Radiation Therapy: Clinical Cases Study. (2014) (0)
MO‐G‐BRC‐05: Impact of Secondary Particles on Linear Energy Transfer for Biological Treatment Planning in Proton Therapy (2011) (0)
Intra-brain vascular models within the ICRP mesh-type adult reference phantoms for applications to internal dosimetry (2023) (0)
Radiationless transition probabilities in muonic209Bi (1992) (0)
TH-D-BRB-02: Improving the Accuracy of Monte Carlo Spread-Out Bragg Peak Treatment Head Models Using Beam Current Modulation Optimization (2010) (0)
Physical and Biological Dose Distribution Due to Primary Protons and Secondary Particles from Nuclear Interactions (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Harald Paganetti?

Harald Paganetti is affiliated with the following schools:

Ludwig Maximilian University of Munich
Massachusetts General Hospital
Harvard University